Painful Understanding of VEGF

Overview

Journal Front Pharmacol

Date 2018 Nov 22

PMID 30459621

Citations 24

Authors

Maria Llorian-Salvador

Sara Gonzalez-Rodriguez

Affiliations

Soon will be listed here.

Citing Articles

Adaptive Autonomic and Neuroplastic Control in Diabetic Neuropathy: A Narrative Review.

Marsili F, Potgieter P, Birkill C Curr Diabetes Rev. 2023; 20(8):38-54.

PMID: 38018186 DOI: 10.2174/0115733998253213231031050044.

The Ca channel ORAI1 is a regulator of oral cancer growth and nociceptive pain.

Son G, Tu N, Santi M, Loya Lopez S, Souza Bomfim G, Vinu M Sci Signal. 2023; 16(801):eadf9535.

PMID: 37669398 PMC: 10747475. DOI: 10.1126/scisignal.adf9535.

Antinociceptive Activity of Vanilloids in Caenorhabditis elegans is Mediated by the Desensitization of the TRPV Channel OCR-2 and Specific Signal Transduction Pathways.

Nkambeu B, Salem J, Beaudry F Neurochem Res. 2023; 48(6):1900-1911.

PMID: 36737562 DOI: 10.1007/s11064-023-03876-1.

Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain.

Ma K, Singh G, Wang J, O-Sullivan I, Votta-Velis G, Bruce B Int J Biol Sci. 2023; 19(2):675-690.

PMID: 36632459 PMC: 9830519. DOI: 10.7150/ijbs.79125.

Neuropilin (NRPs) Related Pathological Conditions and Their Modulators.

Broz M, Kolaric A, Jukic M, Bren U Int J Mol Sci. 2022; 23(15).

PMID: 35955539 PMC: 9368954. DOI: 10.3390/ijms23158402.

References

Kiguchi N, Kobayashi Y, Kadowaki Y, Fukazawa Y, Saika F, Kishioka S . Vascular endothelial growth factor signaling in injured nerves underlies peripheral sensitization in neuropathic pain. J Neurochem. 2013; 129(1):169-78. DOI: 10.1111/jnc.12614. View

von Hehn C, Baron R, Woolf C . Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron. 2012; 73(4):638-52. PMC: 3319438. DOI: 10.1016/j.neuron.2012.02.008. View

Goncalves F, Martins-Oliveira A, Speciali J, Izidoro-Toledo T, Luizon M, Dach F . Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine. DNA Cell Biol. 2010; 29(7):357-62. DOI: 10.1089/dna.2010.1025. View

Woolf C, Salter M . Neuronal plasticity: increasing the gain in pain. Science. 2000; 288(5472):1765-9. DOI: 10.1126/science.288.5472.1765. View

Nagai T, Sato M, Kobayashi M, Yokoyama M, Tani Y, Mochida J . Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis. Arthritis Res Ther. 2014; 16(5):427. PMC: 4189677. DOI: 10.1186/s13075-014-0427-y. View

Hulse R, Beazley-Long N, Ved N, Bestall S, Riaz H, Singhal P . Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration. Clin Sci (Lond). 2015; 129(8):741-56. DOI: 10.1042/CS20150124. View

Taiana M, Lombardi R, Porretta-Serapiglia C, Ciusani E, Oggioni N, Sassone J . Neutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy. PLoS One. 2014; 9(9):e108403. PMC: 4182455. DOI: 10.1371/journal.pone.0108403. View

Stuttfeld E, Ballmer-Hofer K . Structure and function of VEGF receptors. IUBMB Life. 2009; 61(9):915-22. DOI: 10.1002/iub.234. View

Bussolati B, Dunk C, Grohman M, Kontos C, Mason J, Ahmed A . Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol. 2001; 159(3):993-1008. PMC: 1850457. DOI: 10.1016/S0002-9440(10)61775-0. View

10.

De Bandt M, Ben Mahdi M, Ollivier V, Grossin M, Dupuis M, Gaudry M . Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J Immunol. 2003; 171(9):4853-9. DOI: 10.4049/jimmunol.171.9.4853. View

11.

Ferrara N . Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004; 25(4):581-611. DOI: 10.1210/er.2003-0027. View

12.

Basbaum A, Bautista D, Scherrer G, Julius D . Cellular and molecular mechanisms of pain. Cell. 2009; 139(2):267-84. PMC: 2852643. DOI: 10.1016/j.cell.2009.09.028. View

13.

Nowak D, Woolard J, Amin E, Konopatskaya O, Saleem M, Churchill A . Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci. 2008; 121(Pt 20):3487-95. PMC: 2613349. DOI: 10.1242/jcs.016410. View

14.

Afuwape A, Kiriakidis S, Paleolog E . The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol Histopathol. 2002; 17(3):961-72. DOI: 10.14670/HH-17.961. View

15.

Hamilton J, Nagao M, Levine B, Chen D, Olsen B, Im H . Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain. J Bone Miner Res. 2016; 31(5):911-24. PMC: 4863467. DOI: 10.1002/jbmr.2828. View

16.

Carmeliet P . VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005; 69 Suppl 3:4-10. DOI: 10.1159/000088478. View

17.

Di Cesare Mannelli L, Tenci B, Micheli L, Vona A, Corti F, Zanardelli M . Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation. Neuropharmacology. 2017; 131:166-175. DOI: 10.1016/j.neuropharm.2017.12.020. View

18.

Lai H, Shen B, Vijairania P, Zhang X, Vogt S, Gereau 4th R . Anti-vascular endothelial growth factor treatment decreases bladder pain in cyclophosphamide cystitis: a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network animal model study. BJU Int. 2017; 120(4):576-583. PMC: 5716917. DOI: 10.1111/bju.13924. View

19.

Hulse R . Role of VEGF-A in chronic pain. Oncotarget. 2017; 8(7):10775-10776. PMC: 5355219. DOI: 10.18632/oncotarget.14615. View

20.

Peach C, Mignone V, Arruda M, Alcobia D, Hill S, Kilpatrick L . Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2. Int J Mol Sci. 2018; 19(4). PMC: 5979509. DOI: 10.3390/ijms19041264. View